MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$96,207,000
EPS
-$1.03
Unit: Dollar

Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
License revenue
---0
Research and development
77,889,000 70,112,000 63,497,000 39,617,000
General and administrative
32,235,000 31,759,000 39,061,000 22,412,000
Total operating expenses
110,124,000 101,871,000 102,558,000 62,029,000
Loss from operations
-110,124,000 -101,871,000 -102,558,000 -62,029,000
Interest income
14,591,000 13,289,000 12,901,000 2,110,000
Other expense, net
-93,000 -11,000 -314,000 -68,000
Total other income, net
14,498,000 13,278,000 12,587,000 2,042,000
Loss before income taxes
-95,626,000 -88,593,000 -89,971,000 -59,987,000
Income tax expense
581,000 260,000 239,000 358,000
Net loss
-96,207,000 -88,853,000 -90,210,000 -60,345,000
Unrealized gain (loss) on available-for-sale securities, net of tax
--235,000 671,000 -320,000
Foreign exchange translation adjustment, net of tax
--25,000 132,000 -164,000
Comprehensive loss
--89,113,000 -89,407,000 -60,829,000
Basic EPS
-1.03 -1.12 -1.27 -1.67
Diluted EPS
-1.03 -1.12 -1.27 -1.67
Basic Average Shares
93,166,571 79,507,474 71,259,239 36,033,045
Diluted Average Shares
93,166,571 79,507,474 71,259,239 36,033,045
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$96,207,000 (-8.28%↓ Y/Y)Interest income$14,591,000 (9.80%↑ Y/Y)Loss before incometaxes-$95,626,000 (-7.94%↓ Y/Y)Income tax expense$581,000 (123.46%↑ Y/Y)Total other income,net$14,498,000 (9.19%↑ Y/Y)Other expense, net-$93,000 (-745.45%↓ Y/Y)Loss from operations-$110,124,000 (-8.10%↓ Y/Y)Total operatingexpenses$110,124,000 (8.10%↑ Y/Y)Research and development$77,889,000 (11.09%↑ Y/Y)General andadministrative$32,235,000 (1.50%↑ Y/Y)

Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. (TERN)